Stocks · Healthcare · Biotechnology
Maze Therapeutics, Inc. MAZE
$26.43 -0.83% Close, Oct 2, 2026 · NASDAQ · Market cap $1.46B
Strong growth
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $20.0M, up 700.0% from a year earlier, accelerating from -88.1% a quarter earlier.
- Operating margin widened to -728.1% from -5033.2% a year earlier.
- The diluted share count rose 34.5% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 4%
- Revenue growth accelerationTop 2%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 43%
- Gross marginTop 13%
- Operating marginBottom 14%
- Accruals (lower is better)Bottom 43%
- Interest coverBottom 14%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 45%
- Free-cash-flow yieldBottom 43%
- EBITDA / enterprise valueBottom 39%
- Sales / enterprise valueBottom 11%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 37%
- 6-month returnBottom 34%
- 1-year return vs S&P 500Bottom 45%
- Distance from 52-week highBottom 27%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 48%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetTop 28%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 32%
- Maximum drawdown, 3 yearsTop 30%
- Beta vs S&P 500 (lower is better)Top 43%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -88.1% | 700.0% | ↑ |
| Gross margin | 74.0% | 95.3% | ↑ |
| Operating margin | -5033.2% | -728.1% | ↑ |
| FCF margin | -4265.0% | -534.2% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 700.0% | -88.1% | ↑ | Top 4% |
| Gross margin | 95.3% | 74.0% | ↑ | Top 13% |
| Operating margin | -728.1% | -5033.2% | ↑ | Bottom 14% |
| Net margin | -668.0% | -4831.8% | ↑ | — |
| Free-cash-flow margin | -534.2% | -4265.0% | ↑ | — |
| Return on invested capital | -28.4% | — | Bottom 43% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 131.2%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -81.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -1.87%
- Shareholder yield
- -1.87%
- Share count change, 1 year
- +34.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 11, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 7
- Average EPS surprise, last 4
- +2.8%
- Average 2-day reaction, last 8
- -6.5%
- Positive 20 days after report
- 3 of 7
Analysts
- Consensus price target
- $64.00
- Target vs current price
- +142.1%
- Analysts with a rating
- 6
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 12, 2026 | -6.0% | +0.8% | +6.7% | -10.0% | — |
| May 12, 2026 | -4.7% | +1.0% | -4.0% | -6.2% | +11.8% |
| Mar 25, 2026 | +11.0% | -35.2% | -39.1% | -45.9% | -47.6% |
| Nov 6, 2025 | +10.8% | -2.1% | +7.6% | +40.7% | +58.5% |
| Aug 12, 2025 | +2.5% | +2.0% | -0.9% | +21.3% | +140.7% |
| May 14, 2025 | -51.3% | -8.1% | +2.5% | +29.6% | +33.3% |
| Mar 31, 2025 | -4171.1% | -3.6% | -20.6% | -26.6% | -0.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.76 | -$0.72 | -6.0% | — |
| May 12, 2026 | -$0.45 | -$0.43 | -4.7% | $20.0M |
| Mar 25, 2026 | -$0.65 | -$0.73 | +11.0% | — |
| Nov 6, 2025 | -$0.66 | -$0.74 | +10.8% | — |
| Aug 12, 2025 | -$0.77 | -$0.79 | +2.5% | — |
| May 14, 2025 | -$1.15 | -$0.76 | -51.3% | — |
| Mar 31, 2025 | -$18.32 | $0.45 | -4171.1% | — |
| Dec 6, 2024 | -$0.06 | — | — | $2.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 66.03× | — | — | Bottom 11% |
| Free-cash-flow yield | -7.30% | — | — | Bottom 43% |
| Earnings yield | -10.37% | — | — | Bottom 45% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -5.8%
- 200-day average slope (20 days)
- -3.7%
- Distance from 50-day average
- -2.1%
- Distance from 200-day average
- -19.9%
- RSI (14)
- 50.5
- Relative volume
- 0.72×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 66.7%
- Volatility vs own 5-year history
- 39th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.00
- Correlation with S&P 500
- 0.18
- Current drawdown from 1-year high
- -49.0%
- Maximum drawdown, 3 years
- -56.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 12, 2026 | Sep 21, 2026 | -56.8% | 132 days | Not yet recovered |
| Jan 31, 2025 | Apr 8, 2025 | -52.5% | 46 days | 66 days (Jul 15, 2025) |
| Jul 18, 2025 | Aug 8, 2025 | -26.1% | 15 days | 23 days (Sep 11, 2025) |
| Nov 3, 2025 | Nov 7, 2025 | -14.0% | 4 days | 6 days (Nov 17, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.46B
- EPS, diluted (TTM)
- -$2.74
- Revenue (TTM)
- $20.0M
- 52-week range
- $21.95 – $53.65
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $167.5M | $0 |
| Gross profit | $0 | $0 | $167.5M | -$2.4M |
| Operating income | -$111.0M | -$98.6M | $57.6M | -$142.9M |
| Net income | -$114.9M | -$100.4M | $52.2M | -$131.1M |
| EPS (diluted) | -$2.63 | -$2.29 | $0.08 | -$3.05 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5M | $0 | $0 | $0 | $0 | $0 | $20.0M | $0 |
| Net income | -$24.8M | -$29.6M | -$32.8M | -$33.7M | -$30.1M | -$34.6M | -$24.2M | -$44.7M |
| EPS (diluted) | -$0.06 | -$0.11 | -$0.75 | -$0.77 | -$0.66 | -$0.87 | -$0.45 | -$0.76 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Operating cash flow | -$99.2M | -$86.8M | $76.0M | -$111.9M |
| Capital expenditure | -$2.0M | -$441,000 | -$1.1M | -$794,000 |
| Free cash flow | -$101.2M | -$87.3M | $74.8M | -$112.7M |
| Dividends paid | $0 | $0 | $0 | $0 |
| Net share buybacks | $1.7M | $209,000 | $68.4M | $275.8M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $411.1M
- Total assets
- $531.6M
- Total liabilities
- $78.5M
- Total debt
- $60.4M
- Net debt
- -$142.2M
- Shareholders’ equity
- $453.1M
As of Jun 30, 2026 (filed Aug 11, 2026).
Short interest
- Shares sold short
- 5,678,289
- Days to cover
- 10.40
- Change vs previous report
- -4.1%
FINRA short interest, settlement date Sep 15, 2026.